Metall + Plastic joins Optima Group

Published: 1-Jan-2011
Manufacturing Packaging Cleaning

Pharmaceutical filling and closing is united with isolator technology

Metall + Plastic became a part of Optima Group in Schwaebisch Hall, Germany on 1 January 2011. The company, which employs 72 people, is headquartered in Radolfzell and manufactures isolators and e-beam sterilisers used in pharmaceutical filling and packaging lines. Its turnover in 2009 was €19m.

Optima Group Pharma, a leading manufacturer of filling and packaging lines, says the product portfolios of both companies ideally complement each other and the addition of Metall + Plastic’s products completes its portfolio.

Manufacturing at the Metall + Plastic headquarters will continue unchanged and Christoph von Stenglin remains as managing director.

Optima Group says the driving motivation for the acquisition was the ability to bring turnkey solutions to market. The Group now offers a comprehensive range of equipment, including filling and closing systems, pharmaceutical lyophilisation, e-beam sterilisation and barrier technologies (including isolators).

Optima Group Pharma is a subsidiary of the Optima Group, which reported a turnover of €200m in 2009. The Group currently employs 1,200 people and expects further growth in 2011.

  • Companies:
  • Metal and Plastic
See more

You may also like

Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

Read more
OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States

Trending Articles

  1. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding high-volume pre-filled syringe capabilities to its existing fill-finish operations in Switzerland and Livron
  2. Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
  3. Marchesini Group at Interpack 2026 Sustainability, primary packaging, aseptic production, robotics and digital innovation at the heart of this edition
  4. L.B. Bohle hosts successful continuous manufacturing workshop in Brazil Focus on continuous wet granulation and drying for research, development and small-scale production
  5. Symbiosis completes full ICH climatic zone coverage with new stability chamber addition Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
Manufacturing

Optima Pharma expands German pharmaceutical machine assembly capacity

The company will expand operations in Schwaebisch, Radolfzell and Gladenbach to cater to the growing demand for filling systems, isolators and freeze dryers
Packaging

Optima strengthens Indian footprint with Pune site expansion

The company will hire 40 engineering specialists to expand its presence in both the Indian and wider APAC market
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Successfully completing an integrated HPAPI project

Marrying an isolator to a filling and closing line is vital to any fill-and-finish project — especially in systems that process highly potent active ingredients (HPAPIs)
Packaging

Optima in the top 1% of pharmaceutical packaging companies for sustainability

The company has received the EcoVadis platinum award for its sustainability
Packaging

Optima, Pulpac and PA Consulting team up to commercialise dry moulded fibre blister packaging

The trio will facilitate the large-scale production of dry moulded fibre blister packaging, allowing pharma companies to improve their sustainability credentials
Manufacturing

Freeze-drying: producing stable peptides

Biopharmaceutical formulations are often unstable liquids that have a poor shelf-life. This includes raw materials such as peptides and oligonucleotides that are necessary for the production of important drugs. Freeze-drying is one way to convert these sensitive molecules into stable formats, says Stephan Reuter, Managing Director of OPTIMA pharma GmbH
Subscribe now